NEXGEL, Inc. (NXGLW) stock
NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $34.21MP/E –Yield –
Nexgel price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Nexgel's price to sales ratio was 4.7× on Oct 19, 2026, against 32.3× a year earlier. Over the last 5 years it ranged from 2.8× to 141.4×, with a median of 68.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 4.7× | −17.8 |
| 2025 | Dec 31, 2025 | 22.5× | −67.6 |
| 2024 | Dec 31, 2024 | 90.0× | +21.1 |
| 2023 | Dec 29, 2023 | 69.0× | +1.3 |
| 2022 | Dec 30, 2022 | 67.7× | −71.2 |
| 2021 | Dec 31, 2021 | 138.9× | – |